A publication in 2006 studied the effects of two compounds, oxalyl bis (N-phenyl) hydroxamic acid (OBPHA) and copper N-(2-hydroxy acetophenone) glycinate (CuNG), to overcome drug resistance mediated by P-gp, an efflux transporter that pumps chemotherapeutic drugs out of cancer cells. Here, PGP is linked to cancer.